XML 24 R10.htm IDEA: XBRL DOCUMENT v3.19.1
CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
12 Months Ended
Dec. 31, 2018
Cash and Cash Equivalents [Abstract]  
CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
 
Securities classified as cash and cash equivalents and short-term investments as of December 31, 2018 and 2017 are summarized below (in thousands). Estimated fair value is based on quoted market prices for these investments.
 
December 31, 2018
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair Value
Cash and cash equivalents:
 
 
 
 
 
 
 
 
Cash
 
$
95,660

 
$

 
$

 
$
95,660

Money market funds
 
11

 

 

 
11

Agency Bond
 
1,250

 
 
 
 
 
1,250

Commercial paper
 
14,028

 

 

 
14,028

Total cash and cash equivalents
 
110,949

 

 

 
110,949


December 31, 2017
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair Value
Cash and cash equivalents:
 
 
 
 
 
 
 
 
Cash
 
$
103,119

 
$

 
$

 
$
103,119

Money market funds
 
95

 

 

 
95

Commercial paper
 
23,670

 

 

 
23,670

Total cash and cash equivalents
 
126,884

 

 

 
126,884

Short-term investments
 
 
 
 
 
 
 
 
Corporate debt securities and commercial paper with maturities less than 1 year
 
1,210

 

 
(5
)
 
1,205

Total short-term investments
 
1,210

 

 
(5
)
 
1,205

Total
 
$
128,094

 
$

 
$
(5
)
 
$
128,089


 
The Company considers all highly liquid investments with a maturity at date of purchase of three months or less to be cash equivalents. Cash and cash equivalents generally consist of cash on deposit with banks, money market instruments, U.S. Agency discount notes, commercial paper and corporate debt securities.
 
The Company invests its cash in money market funds and marketable securities including U.S. Treasury and government agency securities, commercial paper, and high quality debt securities of financial and commercial institutions. To date, the Company has not experienced material losses on any of its balances. These securities are carried at fair value, which is based on readily available market information, with unrealized gains and losses included in “accumulated other comprehensive loss” within shareholders’ equity on the consolidated balance sheets. The Company uses the specific identification method to determine the amount of realized gains or losses on sales of marketable securities. Realized gains or losses have been insignificant and are included in “interest and other income” in the consolidated statement of operations.
 
At December 31, 2018, the Company had zero securities in an unrealized loss position. The following table shows the gross unrealized losses and fair value of the Company’s investments with unrealized losses that are not deemed to be other‑than‑temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, at December 31, 2017 (in thousands):
 
 
Less than 12 months
 
12 months or greater
 
Total
 
Fair Value
 
Gross
Unrealized
Losses
 
Fair Value
 
Gross
Unrealized
Losses
 
Fair Value
 
Gross
Unrealized
Losses
Corporate debt securities
$
1,205

 
$
(5
)
 
$

 
$

 
$
1,205

 
$
(5
)



The gross unrealized losses above were caused by interest rate increases. No significant facts or circumstances have arisen to indicate that there has been any deterioration in the creditworthiness of the issuers of the securities held by the Company. Based on the Company’s review of these securities, including the assessment of the duration and severity of the unrealized losses and the Company’s ability and intent to hold the investments until maturity, there were no material other‑than‑temporary impairments for these securities at December 31, 2018. Gross realized gains and losses on marketable securities were not material for the years ended December 31, 2018, 2017 and 2016.
 
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.
 
Level 1: Quoted prices in active markets for identical assets or liabilities.
Level 2: Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
The following table represents the Company’s fair value hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2018 (in thousands):
 
December 31, 2018
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
Money market funds
 
$
11

 
$

 
$

 
$
11

Agency bond
 

 
1,250

 

 
1,250

Commercial paper
 

 
14,028

 

 
14,028

Collegium warrants
 
 
 
8,784

 
 
 
8,784

Total
 
$
11

 
$
24,062

 
$

 
$
24,073

Liabilities:
 
 
 
 
 
 
 
 
Contingent consideration—Zipsor
 
$

 
$

 
$
531

 
$
531

Contingent consideration—CAMBIA
 

 

 
507

 
507

Total
 
$

 
$

 
$
1,038

 
$
1,038



The fair value of the warrants to purchase Collegium’s common stock was calculated using the Black-Scholes option pricing model. As of November 8, 2018, the significant inputs included the fair value of Collegium’s common stock of $15.56, an expected term of 4 years and a risk-free rate of 3.05%. As of December 31, 2018, the significant inputs included the fair value of Collegium’s common stock of $17.17, an expected term of 3.86 years and a risk-free rate of 2.48%. The expected term was based on the remaining contractual period of 3.86 years, and the volatility was determined using Collegium’s historical common stock volatility over the expected term.

The fair value measurement of the contingent consideration obligations arises from the Zipsor, CAMBIA and Lazanda acquisitions and relates to fair value of the potential future contingent milestone payments and royalties payable under the respective agreements which are determined using Level 3 inputs. The remaining contingent consideration liability following the divestiture of Lazanda in November 2017 was $0.2 million. This liability was settled in the first quarter of 2018. The key assumptions in determining the fair value are the discount rate and the probability assigned to the potential milestones and royalties being achieved. At each reporting date, the Company re-measures the contingent consideration obligation arising from the above acquisitions to their estimated fair values. Any changes in the fair value of contingent consideration resulting from a change in the underlying inputs are recognized in operating expenses until the contingent consideration arrangement is settled. Changes in the fair value of contingent consideration resulting from the passage of time are recorded within interest expense until the contingent consideration is settled.
 
The table below provides a summary of the changes in fair value recorded in interest expense, selling, general and administrative expense, and gain on divestiture of Lazanda measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the years ended December 31, 2018, 2017 and 2016 (in thousands):
 
 
December 31,
 
2018
 
2017
 
2016
Fair value, beginning of the period
$
1,613

 
$
14,825

 
$
14,971

Changes in fair value recorded in interest expense
124

 
1,079

 
2,408

Changes in fair value recorded in selling, general and administrative expenses
(515
)
 
(7,708
)
 
(122
)
Royalties and milestone paid
(184
)
 
(3,068
)
 
(2,432
)
Divestiture of Lazanda

 
(3,515
)
 

Total
$
1,038

 
$
1,613

 
$
14,825


 
The estimated fair value of the 2.50% Convertible Senior Notes Due 2021, which the Company issued on September 9, 2014 (the 2021 Notes), is based on a market approach. The estimated fair value was approximately $231.8 million (par value $345.0 million) as of December 31, 2018 and represents a Level 2 valuation. The principal amount of the Senior Notes approximates their fair value as of December 31, 2018 and represents a Level 2 valuation. When determining the estimated fair value of the Company’s debt, the Company uses a commonly accepted valuation methodology and market-based risk measurements that are indirectly observable, such as credit risk.
 
There were no transfers between Level 1, Level 2 or Level 3 of the fair value hierarchy during the years ended December 31, 2018 and December 31, 2017.

The following table represents the Company’s fair value hierarchy for its financial assets measured at fair value on a recurring basis as of December 31, 2017 (in thousands):
 
December 31, 2017
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
Money market funds
 
$
95

 
$

 
$

 
$
95

Commercial paper
 

 
23,670

 

 
23,670

Corporate debt securities
 

 
1,205

 

 
1,205

Total
 
$
95

 
$
24,875

 
$

 
$
24,970

Liabilities:
 
 
 
 
 
 
 
 
Contingent consideration—Zipsor
 
$

 
$

 
$
464

 
$
464

Contingent consideration—Lazanda
 

 

 
156

 
156

Contingent consideration—CAMBIA
 

 

 
993

 
993

 
 
$

 
$

 
$
1,613

 
$
1,613